Clomoxir
Clomoxir (POCA) is a carnitine palmitoyltransferase I (CPT I) inhibitor with hypoglycemic activity. Clomoxir mediates the inhibition of CPT I via its active form POCA-CoA. Clomoxir inhibits long-chain fatty acid oxidation, ketogenesis, gluconeogenesis, de novo synthesis of cholesterol and fatty acids, and also mildly inhibits acetyl-CoA carboxylase. Clomoxir reduces blood glucose levels in various rodent and porcine models, alters plasma NEFA and cholesterol concentrations, induces hepatic lipid accumulation, peroxisome proliferation and mild myocardial hypertrophy in rats, and stimulates the pentose phosphate pathway in cultured human fibroblasts. Clomoxir can be used in diabetes-related research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 88431-47-4
- 화학식: C14H17ClO3
- 분자량:268.74
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CPT-1 |
Clomoxir (POCA) exerts multiple metabolic regulatory effects: its coenzyme A ester metabolite inhibits the activity of carnitine palmitoyltransferase in rat liver mitochondria; it suppresses de novo synthesis of cholesterol and fatty acids in the liver, and blocks lactate- and pyruvate-mediated gluconeogenesis stimulated by oleic acid; it activates the pentose phosphate pathway in human fibroblasts[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Clomoxir lowers plasma NEFA and cholesterol concentrations by approximately 50% in rats[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 88431-47-4
-
분자량 268.74
-
화학식 C14H17ClO3
-
SMILES
O=C(O)C1(OC1)CCCCCC2=CC=C(Cl)C=C2
-
Synonyms
POCA
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)